Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Why should I use sharewise

Alexion Pharmaceutical Inc. Stock

Price
Target price
€82.96

€82.96

-0.610%
-0.23
-0.610%
€110.00

€110.00

 
Latest predictions
€95.00
31.03.20
buy
€95.00
12.03.20
buy
€110.00
02.09.19
buy
€130.00
22.08.19
buy
€125.38
26.10.18
buy
Your prediction

Alexion Pharmaceutical Inc. Stock

Alexion Pharmaceutical Inc. shows a slight decrease today, losing -€0.230 (-0.610%) compared to yesterday.
Our community is currently high on Alexion Pharmaceutical Inc. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of €110.00 shows a positive potential of 32.594% compared to the current price of €82.96 for Alexion Pharmaceutical Inc..

Comments

Buy Alexion Pharmaceutical Inc.

Buy Alexion Pharmaceutical Inc.

Published 22.12.19
Prediction Buy
Perf. (%) 9.490%
Target price
Change

Buy beendet

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Alexion Pharmaceutical Inc. Stock

Trading Alexion Pharmaceutical Inc.

Trading Alexion Pharmaceutical Inc.

New thread

News

SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)


Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the extension of the current marketing authorization of SOLIRIS®